Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Rat, Human, Not Applicable|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Human epidermal keratin.|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Immunohistochemistry (Frozen) (IHC (F))||Neat|
|Immunohistochemistry (Paraffin) (IHC (P))||Neat|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA1-26280 detects acidic Cytokeratin from human samples.
MA1-26280 has been successfully used in immunohistochemistry (frozen), and immunohistochemistry (paraffin) procedures.
The MA1-26280 immunogen is human epidermal keratin.
This gene encodes the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this gene cause epidermolytic palmoplantar keratoderma.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Fumarate induces redox-dependent senescence by modifying glutathione metabolism.
MA1-26280 was used in immunohistochemistry - paraffin section to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism
|Zheng L,Cardaci S,Jerby L,MacKenzie ED,Sciacovelli M,Johnson TI,Gaude E,King A,Leach JD,Edrada-Ebel R,Hedley A,Morrice NA,Kalna G,Blyth K,Ruppin E,Frezza C,Gottlieb E||Nature communications (6:null)||2015|
An immunohistochemical study of feline endometrial adenocarcinoma.
MA1-26280 was used in immunohistochemistry - paraffin section to characterize feline endometrial adenocarcinomas immunohistochemically
|Gil da Costa RM,Santos M,Amorim I,Lopes C,Pereira PD,Faustino AM||Journal of comparative pathology (140:254)||2009|
Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report.
MA1-26280 was used in immunohistochemistry to describe a tumor from a patient with oncocytic cystadenoma
|Ba¿ak K,Kiro¿lu K||Medicine (93:null)||2014|
Association of Merkel cell polyomavirus infection with EGFR mutation status in Chinese non-small cell lung cancer patients.
MA1-26280 was used in immunohistochemistry to study Chinese non-small cell lung cancer patients to deterine if there is an association between polyomavirus infection of Merkel cells and EGFR hotspot mutations
|Xu S,Jiang J,Yu X,Sheng D,Zhu T,Jin M||Lung cancer (Amsterdam, Netherlands) (83:341)||2014|
A clinicopathological study of the significance of the proportion of choroid morphology in chordoid meningioma.
MA1-26280 was used in immunohistochemistry to study chordoid menigioma and the significance of the proportion of chordoid morphology for the risk of recurrence
|Lin JW,Lu CH,Lin WC,Wu YT,Huang YJ,Shih FY,Ho JT,Chuang MJ||Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (19:836)||2012|
The prognostic impact of O6-methylguanine DNA methyltransferase and epidermal growth factor receptor expressions on primary gliosarcoma: a clinicopathologic and immunohistochemical study of seven cases at a single institution.
MA1-26280 was used in immunohistochemistry to study the prognostic value of MGMT and EGFR expression in primary gliosarcoma
|Lin JW,Wu YT,Chang IW||Indian journal of pathology and microbiology (54:683)||2012|
Rhabdoid papillary meningioma: a clinicopathologic case series study.
MA1-26280 was used in immunohistochemistry to study the clinicopathology of a series of cases of rhabdoid papillary meningioma
|Wu YT,Ho JT,Lin YJ,Lin JW||Neuropathology : official journal of the Japanese Society of Neuropathology (31:599)||2011|
Clear cell meningioma with frequent chordoid features and aggressive behavior: a clinicopathologic study of ten cases at a single institution.
MA1-26280 was used in immunohistochemistry to study the clinicopathology of clear cell meningioma with frequent chordoid features and aggressive behavior
|Chen HK,Wu YT,Lin YJ,Lin JW||Journal of neuro-oncology (103:551)||2011|
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.
MA1-26280 was used in immunohistochemistry to investigate the efficiency of a new method for the assessment of putative disseminating breast cancer stem cells
|Balic M,Rapp N,Stanzer S,Lin H,Strutz J,Szkandera J,Daidone MG,Samonigg H,Cote RJ,Dandachi N||Applied immunohistochemistry and molecular morphology : AIMM (19:33)||2011|
Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution.
MA1-26280 was used in immunohistochemistry to study the clinicopathology of 11 cases of chordoid meningioma
|Lin JW,Ho JT,Lin YJ,Wu YT||Journal of neuro-oncology (100:465)||2010|
Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts.
MA1-26280 was used in immunohistochemistry to report on a case of melanotic Xp11 translocation renal cancer
|Chang IW,Huang HY,Sung MT||The American journal of surgical pathology (33:1894)||2009|
Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats.
MA1-26280 was used in immunohistochemistry to investigate tumourigenesis in non-mammary tissues in the MNU-induced mammary tumour model
|Esendagli G,Yilmaz G,Canpinar H,Gunel-Ozcan A,Guc MO,Guc D||Laboratory animals (43:60)||2009|
Mediastinal intraoperative radioisotope sentinel lymph node mapping in non-small-cell lung cancer.
MA1-26280 was used in immunohistochemistry to develop a method to map sentinel lymph nodes in non-small cell lung cancer patients
|Atinkaya C,Ozlem Küçük N,Koparal H,Aras G,Sak SD,Ozdemir N||Nuclear medicine communications (26:717)||2005|
Ectopic thyroid in the gallbladder: report of a case.
MA1-26280 was used in immunohistochemistry to describe an unusual case of ectopic thyroid tissue
|Ihtiyar E,Isiksoy S,Algin C,Sahin A,Erkasap S,Yasar B||Surgery today (33:777)||2003|
Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
MA1-26280 was used in western blot to study the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines
|Chang CY,Chiou PP,Chen WJ,Li YH,Yiu JC,Cheng YH,Chen SD,Lin CT,Lai YS||Research in veterinary science (88:285)||2010|
Possible association between HPV16 E7 protein level and cytokeratin 19.
MA1-26280 was used in western blot to study the association between HPV16 E7 protein levels and cytokeratin 19
|Favia G,Kanduc D,Lo Muzio L,Lucchese A,Serpico R||International journal of cancer (111:795)||2004|
CK-9; cytokeratin 9; Cytokeratin-9; EPPK; K9; keratin 9, type I; Keratin, type I cytoskeletal 9; Keratin-9; type I cytoskeletal 9
CK-9; EPPK; K9; KRT9